The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...

TANZANIA: SICKLE Cell Disease (SCD) remains a significant health burden, particularly in Africa where approximately 80 per ...

Taking prescribed beta blockers during hematopoietic stem cell transplantation may increase mortality risk due to suppression ...

Hoops Scouting USA, a basketball website, engages in scouting high school and college basketball players in Colorado, the United States. It allows high school players to set up accounts, including ...

INB-100, given following hematopoietic stem cell transplantation (HSCT), is demonstrating the potential to achieve durable long-term remissions and improved survival. The data will be presented at the ...

Defibrotide prophylaxis after HSCT did not reduce sinusoidal obstructive syndrome incidence in high-risk pediatric patients, per retrospective study at 2025 Tandem Meeting.

Patients with childhood and young adult cancer have an increased long-term risk for diabetes, noted as early as 10 years ...

总之，INB-100的成功应用标志着细胞疗法在急性髓系白血病治疗中的潜力。未来，通过持续改进与探索，或许我们能够真正实现让白血病患者摆脱复发困扰的日子，如今回望最初的问题，细胞疗法无复发的成果是否将成为新常态？

FDA已授予 SER-155 突破性疗法认定，用于减少接受异基因造血干细胞移植 (allo-HSCT) 治疗血液系统恶性肿瘤的成年人的血流感染 (BSI)。 美国食品药品监督管理局 (FDA) 已授予 SER-155 ...

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...